Anoat Therapeutics Company Profile, Contacts & Intelligence
Biotechnology Research6 employeesFounded 2023
Employees
6
Company source estimate
Anoat Therapeutics Overview
Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. The Anoat team leverages its proven track record in rare diseases and AntiSense Oligonucleotide (ASO) drug development to build a pipeline of novel drug candidates. Anoat’s lead program is an ASO designed to target an alternative chloride channel and compensate for the defective/lacking activity of the CFTR (Cystic Fibrosis Transmembrane conductance Regulator) channel protein in Cystic Fibrosis (CF) patients.
- Industry
- Biotechnology Research
- Founded
- 2023
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Compare Similar Companies to Anoat Therapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Coave Therapeutics | Biotechnology Research | 45 | View company |
| AevisBio, Inc | Biotechnology Research | 7 | View company |
| Calida Therapeutics | Biotechnology Research | 5 | View company |
| AndzonBio1 | Biotechnology Research | 3 | View company |
| Cultured Therapeutics | Medical Practices | 2 | View company |
| Disperazol Pharma ApS | Biotechnology Research | 1 | View company |
| NSBIOTECH | Higher Education | 1 | View company |
| Predictive, LLC | Software Development | 1 | View company |
| Biotech Corpo & BD Consulting | Biotechnology Research | Not listed | View company |
| Lumento Therapeutics | Biotechnology Research | Not listed | View company |